Recent years have witnessed groundbreaking advances in the field of diabetes treatment, with a particular focus on GLP-1 receptor agonists. Among these novel therapies, retatrutide and trizepatide are emerging as https://jesseuzxg365032.atualblog.com/45533872/glp-1-receptor-agonists-retatrutide-and-trizepatide-advancements